Changes of Matrix Metalloproteinases in the Stroma After Corneal Cross-linking in Rabbits

Overview

Journal Int J Ophthalmol

Specialty Ophthalmology

Date 2021 Jan 20

PMID 33469480

Citations 3

Authors

Hong-Zhen Jia

Xu Pang

Xiu-Jun Peng

Affiliations

Soon will be listed here.

Abstract

Aim: To observe changes in the content of matrix metalloproteinases (MMPs) in the corneal stroma after corneal cross-linking (CXL) in rabbits, and further explore the corneal pathophysiological process after CXL.

Methods: Forty-two rabbits (42 eyes) were randomly divided into seven groups. One group served as the control group, while the other six groups were treated with CXL. The concentrations of MMPs in corneal stroma were evaluated through parallel reaction monitoring at baseline and 3, 7, 15, 30, 90, and 180d after treatment.

Results: The levels of MMP-2 in the corneal stroma of rabbits were 0.76±0.07, 2.78±1.39, 4.12±0.69, 2.00±0.29, 2.00±0.30, 1.22±0.18, and 1.35±0.18 (10 mol/g) at baseline and 3, 7, 15, 30, 90, and 180d after treatment, respectively. The contents of tissue inhibitor of metalloproteinase-1 (TIMP-1) were 1.83±0.26, 7.94±0.58, 6.95±2.64, 3.81±0.48, 3.07±0.92, 1.72±0.19, and 1.69±0.74 (10 mol/g), respectively. The ratios of MMP-2/TIMP-1 were 0.42±0.33, 0.36±0.20, 0.62±0.10, 0.54±0.15, 0.68±0.13, 0.71±0.10, and 0.68±0.09, respectively. After CXL, the expression of MMP-2 and TIMP-1 in the rabbit corneal stroma was initially increased and subsequently decreased. The levels of MMP-2 remained higher than those recorded at baseline 180d after treatment, but it was not statistically significant. The levels of TIMP-1 returned to baseline levels at 90d after treatment. The ratio of MMP-2/TIMP-1 started to rise from 7d after CXL. It was significantly higher than that calculated at baseline 30-180d after CXL. The results for MMP-1, -3, -7, -9, -13, and TIMP-2 were negative.

Conclusion: CXL can lead to changes in the content of MMP-2 and TIMP-1 in the rabbit corneal stroma. The ratio of MMP-2/TIMP-1 remains higher versus baseline, indicating that MMP-2 is involved in the corneal pathophysiological process after CXL.

Citing Articles

Analysis of Smad3 in the modulation of stromal extracellular matrix proteins in corneal scarring after alkali injury.

Gupta S, Zhang E, Sinha S, Martin L, Varghese T, Forck N Mol Vis. 2025; 30:448-464.

PMID: 39959170 PMC: 11829792.

Effectiveness and biocompatibility of a novel Schlemm's canal microstent for glaucoma management.

Huang M, Zhang Y, Chen Z, Liu C, Wang J, Feng X Sci Rep. 2024; 14(1):24919.

PMID: 39438649 PMC: 11496681. DOI: 10.1038/s41598-024-76789-w.

Shark Cartilage-Derived Anti-Angiogenic Peptide Inhibits Corneal Neovascularization.

Li Y, Chen A, Hong A, Xiong S, Chen X, Xie Q Bioengineering (Basel). 2024; 11(7).

PMID: 39061775 PMC: 11273382. DOI: 10.3390/bioengineering11070693.

Vitamin D Supplementation Impacts Systemic Biomarkers of Collagen Degradation and Copper Metabolism in Patients With Keratoconus.

Lasagni Vitar R, Fonteyne P, Knutsson K, Bertuzzi F, Galli L, Rama P Transl Vis Sci Technol. 2022; 11(12):16.

PMID: 36580321 PMC: 9804020. DOI: 10.1167/tvst.11.12.16.

References

Sakimoto T, Sawa M . Metalloproteinases in corneal diseases: degradation and processing. Cornea. 2012; 31 Suppl 1:S50-6. DOI: 10.1097/ICO.0b013e318269ccd0. View

Wollensak G, Spoerl E, Seiler T . Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003; 135(5):620-7. DOI: 10.1016/s0002-9394(02)02220-1. View

Kalkanci A, Bilgihan K, Ozdemir H, Saglam A, Karakurt F, Erdogan M . Corneal Cross-Linking Has No Effect on Matrix Metalloproteinase 9 and 13 Levels During Fungal Keratitis on the Early Stage. Mycopathologia. 2017; 183(2):329-336. DOI: 10.1007/s11046-017-0207-8. View

di Martino E, Ali M, Inglehearn C . Matrix metalloproteinases in keratoconus - Too much of a good thing?. Exp Eye Res. 2019; 182:137-143. DOI: 10.1016/j.exer.2019.03.016. View

Zhang Y, Mao X, Schwend T, Littlechild S, Conrad G . Resistance of corneal RFUVA–cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases. Invest Ophthalmol Vis Sci. 2013; 54(2):1014-25. PMC: 4604715. DOI: 10.1167/iovs.12-11277. View

Sprung R, Martinez M, Carpenter K, Ham A, Washington M, Arteaga C . Precision of multiple reaction monitoring mass spectrometry analysis of formalin-fixed, paraffin-embedded tissue. J Proteome Res. 2012; 11(6):3498-505. PMC: 3368395. DOI: 10.1021/pr300130t. View

Kenney M, Chwa M, Alba A, Saghizadeh M, Huang Z, Brown D . Localization of TIMP-1, TIMP-2, TIMP-3, gelatinase A and gelatinase B in pathological human corneas. Curr Eye Res. 1998; 17(3):238-46. DOI: 10.1076/ceyr.17.3.238.5222. View

Mohammadpour M, Masoumi A, Mirghorbani M, Shahraki K, Hashemi H . Updates on corneal collagen cross-linking: Indications, techniques and clinical outcomes. J Curr Ophthalmol. 2017; 29(4):235-247. PMC: 5735256. DOI: 10.1016/j.joco.2017.07.003. View

Mohamed-Noriega K, Butron-Valdez K, Vazquez-Galvan J, Mohamed-Noriega J, Cavazos-Adame H, Mohamed-Hamsho J . Corneal Melting after Collagen Cross-Linking for Keratoconus in a Thin Cornea of a Diabetic Patient Treated with Topical Nepafenac: A Case Report with a Literature Review. Case Rep Ophthalmol. 2016; 7(1):119-24. PMC: 4899655. DOI: 10.1159/000444437. View

10.

Kenney M, Chwa M, Atilano S, Tran A, Carballo M, Saghizadeh M . Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder. Invest Ophthalmol Vis Sci. 2005; 46(3):823-32. DOI: 10.1167/iovs.04-0549. View

11.

Mazzotta C, Traversi C, Mellace P, Bagaglia S, Zuccarini S, Mencucci R . Keratoconus Progression in Patients With Allergy and Elevated Surface Matrix Metalloproteinase 9 Point-of-Care Test. Eye Contact Lens. 2017; 44 Suppl 2:S48-S53. DOI: 10.1097/ICL.0000000000000432. View

12.

Aldahlawi N, Hayes S, OBrart D, OBrart N, Meek K . An investigation into corneal enzymatic resistance following epithelium-off and epithelium-on corneal cross-linking protocols. Exp Eye Res. 2016; 153:141-151. PMC: 5131611. DOI: 10.1016/j.exer.2016.10.014. View

13.

Wong T, Sethi C, Daniels J, Limb G, Murphy G, Khaw P . Matrix metalloproteinases in disease and repair processes in the anterior segment. Surv Ophthalmol. 2002; 47(3):239-56. DOI: 10.1016/s0039-6257(02)00287-4. View

14.

Smith V, Matthews F, Majid M, Cook S . Keratoconus: matrix metalloproteinase-2 activation and TIMP modulation. Biochim Biophys Acta. 2006; 1762(4):431-9. DOI: 10.1016/j.bbadis.2006.01.010. View

15.

Mastropasqua L, Lanzini M, Curcio C, Calienno R, Mastropasqua R, Colasante M . Structural modifications and tissue response after standard epi-off and iontophoretic corneal crosslinking with different irradiation procedures. Invest Ophthalmol Vis Sci. 2014; 55(4):2526-33. DOI: 10.1167/iovs.13-13363. View

16.

Balasubramanian S, Pye D, Willcox M . Effects of eye rubbing on the levels of protease, protease activity and cytokines in tears: relevance in keratoconus. Clin Exp Optom. 2013; 96(2):214-8. DOI: 10.1111/cxo.12038. View

17.

Xia Y, Liu B, Fan Z, Peng X . Corneal collagen fibril changes after ultraviolet a/riboflavin corneal crosslinking. Cornea. 2013; 33(1):56-9. DOI: 10.1097/ICO.0000000000000017. View

18.

Wollensak G, Iomdina E, Dittert D, Herbst H . Wound healing in the rabbit cornea after corneal collagen cross-linking with riboflavin and UVA. Cornea. 2007; 26(5):600-5. DOI: 10.1097/ICO.0b013e318041f073. View

19.

Wojcik K, Blasiak J, Szaflik J, Szaflik J . Role of biochemical factors in the pathogenesis of keratoconus. Acta Biochim Pol. 2014; 61(1):55-62. View

20.

Kolozsvari B, Berta A, Petrovski G, Mihaltz K, Gogolak P, Rajnavolgyi E . Alterations of tear mediators in patients with keratoconus after corneal crosslinking associate with corneal changes. PLoS One. 2013; 8(10):e76333. PMC: 3790710. DOI: 10.1371/journal.pone.0076333. View